Filing Flows › Volitionrx (VNRX) › Q2 2026
Volitionrx (VNRX) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 13, 2026
Volitionrx (VNRX) reported revenue of $399K for the second quarter 2026 (Q2 2026), -2% from a year earlier and -60% from the quarter before.
Volitionrx, Q2 2026: revenue $399K (-2% year over year), net loss $7.3M, operating cash flow −$5.2M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $399K | -60% | -2% |
| Operating profit | −$4.2M | — | — |
| Net earnings | −$7.3M | — | — |
| Operating cash flow | −$5.2M | — | — |
What changed
Revenue was $399K in Q2 2026, down 2% year over year and down 60% from the previous quarter.
Operating costs exceeded revenue by $4.2M, an operating margin of -1042.5%. Total costs fell 32% while revenue fell 2%. The quarter ended with a net loss of $7.3M, wider than the previous quarter's $6.7M loss.
Operating cash flow was −$5.2M. Non-cash charges added back $188K of depreciation and amortization and $238K of share-based compensation. Working capital and other items added $1.7M. Capital expenditures of $2K exceeded it, leaving free cash flow of −$5.2M.
Questions
What was Volitionrx's revenue in the second quarter 2026?
Volitionrx (VNRX) reported revenue of $399K for the second quarter 2026 (Q2 2026), -2% from a year earlier and -60% from the quarter before.
Source: Volitionrx 10-Q on SEC EDGAR.